Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform

Fundamental and Clinical Pharmacology

Volumn 11, Issue 3, 1997, Pages 252-259

  Beverelli, F ^a   Bea M L ^a   Puybasset, L ^a   Giudicelli, J F ^a   Bordeaux, A ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Bradykinin; Coronary artery; Cyclooxygenase; Endothelium; Indomethacin; NO synthase; Prostacyclin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; BRADYKININ; CYCLOOXYGENASE 1; INDOMETACIN; ISOENZYME; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) METHYLARGININE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; ENZYME INHIBITION; ENZYME REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030961351     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00193.x     Document Type: Article

References (31)

1. Altman J, Dulas D, Bache RJ. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels. Circ Res 1992;70:1091-8
2. Arnal JF, Warin L, Michel JB. Determinant of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90:647-52
3. Berthiaume F, Frangos JA. Flow-induced prostacyclin production is mediated by a pertussis toxin-sensitive G protein. FEBS Letter 1992;308:277-9
4. Chan CC, Boyce S, Brideau C. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-735,337: a novel nonsteroidal antiinflammatory agent (NSAID) with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995;274:1531-7
5. Doni MG, Whittle B, Palmer RMJ, Moncada S. Action of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 1988;151:19-25
6. Engelhardt G. Meloxicam, a potent inhibitor of COX-2. In: Proceedings of the 9th International Conference on Prostaglandins and Related Compounds. Florence, Milan: Giovanni Lorenzini Medical Foundation 1994;6-10
7. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24
8. Frangos JA, Eskin SG, Mcintyre LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985;227:1477-9
9. Futaki N, Takahashi S, Yokoyama M, Arai I et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase / cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-9
10. Garcia Rodriguez LA, Jick H. Risks of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;47:55-9
11. Glaser K, Sung ML, O'neil K, Belfast M et al. Etodolac selectively inhibits human prostaglandin G/H synthase-2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995; 281:107-11
12. Hecker M, Mülsch A, Bassenge E, Busse R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol 1993;265:H828-33
13. Ito A, Egashira K, Kadokami T, Fukumoto Y et al. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 1995;92: 2636-44
14. Laneuville O, Breuer DK, Dewitt DL, Hla T et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by non-steroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34
15. Meade EA, Smith WL, Dewitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal and anti-inflammatory drugs. J Biol Chem 1993;268:6610-14
16. Mitchell JA, Akarasereenont P, Thiermermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci 1994;90:11693-97
17. Mombouli JV, Iliano S, Nagao T, Scott-Burden TV, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992;71: 137-44
18. Mombouli JV, Makashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by excercice-training. Br J Pharmacol 1996;117:413-18
19. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis and endogenous roles of nitric oxide. Pharmacol. Rev 1991;43:109-42
20. North AJ, Brannon TS, Wells LB, Campbell WB, Shaul PW. Hypoxia stimulates prostacyclin synthesis in newborn pulmonary artery endothelium by increasing cyclooxygenase-1 protein. Circ Res 1994;75:33-40
21. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996;10:1-15
22. Panara MR, Greco A, Santini G, Sciulli MG et al. Effects of the novel antiinflammatory compounds, N-[2-cyclohexyloxy-4-nitrophenyl]-methanesulfonamide (NS-398) and 5-methanesulfonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745337), on the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. Br J Pharmacol 1995;116:2429-34
23. Puybasset L, Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Circ Res 1996;79:343-57
24. Richard V, Tanner FC, Tschudi M, Luscher TF. Different activation of L-arginine pathway by bradykinin, serotonin, and clonidin in coronary arteries. Am J Physiol 1990;259: H1433-9
25. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercice in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-53
26. Stadler J, Harbrecht BG, Di Silvio M, Curran RD et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat kupffer cells. J Leukoc Biol 1993;53:165-72
27. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-42
28. Vanhoutte PM. The end of the quest? Nature Lond 1987;327: 459-60
29. Vanhoutte PM. Endothelium and control of vascular function. Hypertension 1989;13:658-67
30. Wang J, Wolin MS, Hintze TH. Chronic exercice enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res 1993;73:829-38
31. Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and ionophore A23187. J Clin Invest 1978;62:923